Bipolar Depression
Research Study
Some adults with bipolar depression still struggle with symptoms even after trying many treatments, and researchers don’t yet know why. These symptoms may be connected to brain circuits that control reward and emotions. This study will explore how these circuits function and test new treatment options to help guide better treatments in the future.
Fast Facts
Adults diagnosed with bipolar depression
Ages 22–64
Compensation provided
Conducted in Houston, TX
Additional Information
In this research study, Baylor College of Medicine aims to better understand treatment-resistant bipolar depression by examining brain circuits involved in mood, motivation, and reward. Symptoms such as anhedonia may be linked to disruptions in these brain systems. This study uses neuroscience-guided approaches, including investigational treatments, to better understand and potentially improve depressive symptoms. Findings from this research may help inform future treatment options for individuals with treatment-resistant bipolar depression.
You may be eligible for this study if you meet the following criteria.
Inclusion Criteria:
- Adults aged 22–64
- Diagnosed with Bipolar I Disorder
- Have not responded to at least 4 prior treatments for bipolar depression, including 2 treatments during the current depressive episode
- Currently taking a mood stabilizer (e.g., lithium)
Exclusion Criteria:
- Schizophrenia or other psychotic disorders
- Current alcohol or substance use disorder
- Pregnancy
- Inability to undergo MRI (e.g., claustrophobia, non-removable metal in body)
The entire study lasts approximately 20 months. Once enrolled, participation involves:
In the clinic:
- About 23 study visits, including medical, psychiatric, and cognitive evaluations.
- The treatment involves Deep Brain Stimulation (DBS), a surgical procedure that is also used to treat other neurological and psychiatric conditions, including treatment-resistant Parkinson’s disease and obsessive-compulsive disorder (OCD).
- Some study visits will involve adjustment of the device by the study psychiatrist to optimize treatment.
- Assessments include interviews, questionnaires, neuropsychological testing, and MRI scans.
- Certain visits will require a 24-hour stay at the Menninger NeuroBehavioral Monitoring Unit (NBU), which will be covered by the study team.
- The first visit also includes a blood draw.
At home / remote monitoring:
- Participants will complete app-based assessments tracking mood, behavior, and daily experiences.
- You may be asked to complete short surveys several times per day for specific periods during the study.
- Surveys take less than 5 minutes each, and the app may collect behavioral data to better understand mood and daily functioning.
As a participant, you will be compensated for your time and participation.
There is no cost for you to participate in our research study.